TRIMEBUTINE VIATRIS 200 mg, film-coated tablet 30 tablets, CIP 3400935919588
Active ingredients: Trimebutine maleate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400935919588orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIMEBUTINE VIATRIS 200 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 15%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Douleurs liées à des troubles fonctionnels digestifs<br>- Douleurs, troubles du transit et inconfort intestinal liés à des troubles fonctionnels intestinaux. ; JOURNAL OFFICIEL ; 02/10/15
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Nov 2006
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65960119CIP73591958CIP133400935919588Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TRIMÉBUTINEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.